• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于常规实验室指标的无创评估对慢性乙型肝炎患者晚期肝纤维化评估的回顾性研究

Retrospective Evaluation of Non-Invasive Assessment Based on Routine Laboratory Markers for Assessing Advanced Liver Fibrosis in Chronic Hepatitis B Patients.

作者信息

Wang Zeyu, Zhou Yonghe, Yu Pengzhi, Liu Yonggang, Mei Mei, Bian Zhuo, Shao Wei, Lv Jinxia, Li Xin, Lu Wei, Xu Liang

机构信息

Department of Hepatobiliary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, People's Republic of China.

Ultrasound department, Tianjin Second People's Hospital, Tianjin, 300192, People's Republic of China.

出版信息

Int J Gen Med. 2022 May 25;15:5159-5171. doi: 10.2147/IJGM.S364216. eCollection 2022.

DOI:10.2147/IJGM.S364216
PMID:35642202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9148603/
Abstract

BACKGROUND

At present, there is a lack of cheap, effective and convenient detection methods for hepatitis B-related liver fibrosis, especially in the developing area.

AIM

To evaluate the non-invasive methods for the significant and advanced fibrosis stage in chronic hepatitis B virus (HBV) patients in basic hospitals and to assess their diagnostic utility.

METHODS

The study included 436 consecutive naive HBV individuals who had their livers biopsied. They were examined in one week using aspartate aminotransferase-to-aspartate aminotransferase ratio (AAR), age-platelet index (API), aspartate aminotransferase-to-platelet ratio index (APRI), fibrosis-4 (FIB-4), Forns, gamma-glutamyl transpeptidase-to-platelet ratio (GPR), S-index and transient elastography (TE). Scheuer scoring system was used to determine the histologic fibrosis grades (S0-S4). The diagnostic effectiveness was assessed using AUROCs and the DeLong test, both of which were based on statistical comparisons.

RESULTS

For both substantial (≧S2) and advanced (≧S3) fibrosis phases, TE had good diagnostic performance in determining the hepatic fibrosis. Similar diagnostic performance was shown with Forns and S-index when it came to detecting fibrosis stages lower than S3. One model's diagnostic value was not significantly improved by combining serum models. Correlation coefficients between clinical features and fibrosis phases were greatest for Forns ( = 0.397), S-index ( = 0.382) and TE ( = 0.535) when compared to other variables.

CONCLUSION

This investigation showed that Forns and S-index may be helpful strategies for detecting advanced fibrosis in HBV patients admitted to community hospitals.

摘要

背景

目前,对于乙型肝炎相关肝纤维化,缺乏廉价、有效且便捷的检测方法,尤其是在发展中地区。

目的

评估基层医院慢性乙型肝炎病毒(HBV)患者显著和晚期纤维化阶段的非侵入性方法,并评估其诊断效用。

方法

该研究纳入了436例连续的初治HBV个体,这些个体均接受了肝脏活检。在一周内,使用天冬氨酸转氨酶与天冬氨酸转氨酶比值(AAR)、年龄-血小板指数(API)、天冬氨酸转氨酶与血小板比值指数(APRI)、纤维化-4(FIB-4)、Forns指数、γ-谷氨酰转肽酶与血小板比值(GPR)、S指数和瞬时弹性成像(TE)对他们进行检查。采用Scheuer评分系统确定组织学纤维化分级(S0-S4)。使用基于统计比较的受试者工作特征曲线下面积(AUROCs)和DeLong检验评估诊断有效性。

结果

对于显著(≧S2)和晚期(≧S3)纤维化阶段,TE在确定肝纤维化方面具有良好的诊断性能。在检测低于S3的纤维化阶段时,Forns指数和S指数显示出类似的诊断性能。血清模型联合使用并未显著提高一种模型的诊断价值。与其他变量相比,Forns指数(=0.397)、S指数(=0.382)和TE(=0.535)与临床特征和纤维化阶段之间的相关系数最大。

结论

本研究表明,Forns指数和S指数可能是检测社区医院收治的HBV患者晚期纤维化的有用策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29b/9148603/0510082a6848/IJGM-15-5159-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29b/9148603/87523d46f7a0/IJGM-15-5159-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29b/9148603/0510082a6848/IJGM-15-5159-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29b/9148603/87523d46f7a0/IJGM-15-5159-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29b/9148603/0510082a6848/IJGM-15-5159-g0002.jpg

相似文献

1
Retrospective Evaluation of Non-Invasive Assessment Based on Routine Laboratory Markers for Assessing Advanced Liver Fibrosis in Chronic Hepatitis B Patients.基于常规实验室指标的无创评估对慢性乙型肝炎患者晚期肝纤维化评估的回顾性研究
Int J Gen Med. 2022 May 25;15:5159-5171. doi: 10.2147/IJGM.S364216. eCollection 2022.
2
Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns' index in chronic hepatitis C virus.Egy-Score 对慢性丙型肝炎病毒患者显著、晚期肝纤维化和肝硬化的诊断价值与天门冬氨酸氨基转移酶/血小板比值指数、FIB-4 和 Forns 指数的比较。
Hepatol Res. 2015 May;45(5):560-70. doi: 10.1111/hepr.12385. Epub 2014 Aug 6.
3
Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase.γ-谷氨酰转肽酶与血小板比值可预测丙氨酸氨基转移酶正常的乙肝e抗原阴性慢性乙型肝炎患者的肝损伤
J Clin Transl Hepatol. 2022 Apr 28;10(2):247-253. doi: 10.14218/JCTH.2021.00151. Epub 2021 Jul 14.
4
AST-platelet ratio index, Forns index and FIB-4 in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis C.丙氨酸氨基转移酶-血小板比率指数、福尔恩斯指数和FIB-4在预测慢性丙型肝炎患者显著肝纤维化和肝硬化中的应用
Turk J Gastroenterol. 2011 Jun;22(3):279-85. doi: 10.4318/tjg.2011.0213.
5
Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B.基于四个因素以及红细胞分布宽度与血小板比值,在慢性乙型肝炎肝纤维化和炎症诊断中,天冬氨酸转氨酶与血小板比值指数及γ-谷氨酰转肽酶与血小板比值比纤维化指数更具优势。
J Clin Lab Anal. 2018 May;32(4):e22341. doi: 10.1002/jcla.22341. Epub 2017 Dec 18.
6
The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.γ-谷氨酰转肽酶与血小板比值在诊断慢性乙型肝炎患者显著纤维化和肝硬化方面并不优于APRI和Fib-4:一项中国的回顾性队列研究
Medicine (Baltimore). 2016 Apr;95(16):e3372. doi: 10.1097/MD.0000000000003372.
7
GPR, King's Score and S-Index are superior to other non-invasive fibrosis markers in predicting the liver fibrosis in chronic Hepatitis B patients.GPR、King's 评分和 S-指数优于其他非侵入性纤维化标志物,可预测慢性乙型肝炎患者的肝纤维化。
Acta Gastroenterol Belg. 2022 Jan-Mar;85(1):62-68. doi: 10.51821/85.1.9156.
8
The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.在中国,γ-谷氨酰转肽酶与血小板比值可预测乙肝e抗原阳性、乙肝病毒DNA水平高且丙氨酸转氨酶水平正常或轻度升高的慢性乙肝病毒感染患者的肝纤维化和肝硬化情况。
J Viral Hepat. 2016 Nov;23(11):912-919. doi: 10.1111/jvh.12563. Epub 2016 Jul 4.
9
Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B.慢性乙型肝炎中,非侵入性纤维化检测诊断准确性的下降与丙氨酸氨基转移酶升高有关。
World J Clin Cases. 2018 Oct 26;6(12):521-530. doi: 10.12998/wjcc.v6.i12.521.
10
The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.非侵入性检测对慢性乙型肝炎患者肝纤维化评估的诊断价值。
Scand J Clin Lab Invest. 2013;73(4):300-8. doi: 10.3109/00365513.2013.773592. Epub 2013 Mar 20.

引用本文的文献

1
The Use of Serum Scoring Systems in Predicting Liver Fibrosis Caused by Chronic Hepatitis B: A Retrospective Case-Control Study.血清评分系统在预测慢性乙型肝炎所致肝纤维化中的应用:一项回顾性病例对照研究
Medicina (Kaunas). 2025 Aug 20;61(8):1490. doi: 10.3390/medicina61081490.
2
Prevalence of Non-Alcoholic Fatty Liver Disease and Its Impact on Fibrosis Risk in Inactive Chronic Hepatitis B Patients: Insights from a Cross-Sectional Study.非酒精性脂肪性肝病在慢性乙型肝炎非活动期患者中的患病率及其对纤维化风险的影响:一项横断面研究的见解
J Clin Med. 2024 Aug 12;13(16):4738. doi: 10.3390/jcm13164738.
3
Non-invasive assessment of hepatic fibrosis among patients with chronic hepatitis B virus infection in three tertiary hospitals in Nigeria.

本文引用的文献

1
Acoustic radiation force impulse elastography and liver fibrosis risk scores in severe obesity.声辐射力脉冲弹性成像与严重肥胖患者肝纤维化风险评分。
Arch Endocrinol Metab. 2021 Nov 24;65(6):730-738. doi: 10.20945/2359-3997000000397. Epub 2021 Nov 11.
2
Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.FibroTouch 及无创性纤维化指数在不同病因所致肝纤维化中的诊断价值。
Dig Dis Sci. 2022 Jun;67(6):2627-2636. doi: 10.1007/s10620-021-07049-4. Epub 2021 May 31.
3
INR-to-platelet ratio (INPR) as a novel noninvasive index for predicting liver fibrosis in chronic hepatitis B.
尼日利亚三家三级医院慢性乙型肝炎病毒感染患者肝纤维化的无创评估
SAGE Open Med. 2024 Aug 7;12:20503121241264313. doi: 10.1177/20503121241264313. eCollection 2024.
4
Novel noninvasive indices for the assessment of liver fibrosis in primary biliary cholangitis.用于评估原发性胆汁性胆管炎肝纤维化的新型非侵入性指标。
Biomed Rep. 2023 Nov 13;20(1):1. doi: 10.3892/br.2023.1689. eCollection 2024 Jan.
INR-血小板比值(INPR)作为一种新型的无创性指数,可用于预测慢性乙型肝炎的肝纤维化。
Int J Med Sci. 2021 Jan 9;18(5):1159-1166. doi: 10.7150/ijms.51799. eCollection 2021.
4
FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients.FibroBox:一种用于预测乙肝病毒感染患者显著肝纤维化和肝硬化的新型非侵入性工具。
Biomark Res. 2020 Sep 25;8:48. doi: 10.1186/s40364-020-00215-2. eCollection 2020.
5
Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients.血清铜蓝蛋白可预测乙型肝炎病毒感染者的肝纤维化。
World J Gastroenterol. 2020 Jul 21;26(27):3952-3962. doi: 10.3748/wjg.v26.i27.3952.
6
A Novel Diagnostic Nomogram for Noninvasive Evaluating Liver Fibrosis in Patients with Chronic Hepatitis B Virus Infection.一种新型的无创诊断列线图,用于评估慢性乙型肝炎病毒感染患者的肝纤维化程度。
Biomed Res Int. 2020 Jun 2;2020:5218930. doi: 10.1155/2020/5218930. eCollection 2020.
7
Risk factors for hepatitis B and C among healthy population: a community-based survey from four districts of Southern Italy.意大利南部四个地区的基于社区的健康人群乙肝和丙肝的危险因素调查。
Infez Med. 2020 Jun 1;28(2):223-226.
8
Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus.血清 N-糖基化标志物用于诊断乙型肝炎病毒引起的肝纤维化。
World J Gastroenterol. 2020 Mar 14;26(10):1067-1079. doi: 10.3748/wjg.v26.i10.1067.
9
Effects of laparoscopic splenectomy and azygoportal disconnection on liver synthesis function and cirrhosis: a 2-year prospective study.腹腔镜脾切除术和奇静脉断流术对肝脏合成功能和肝硬化的影响:一项 2 年的前瞻性研究。
Surg Endosc. 2020 Nov;34(11):5074-5082. doi: 10.1007/s00464-019-07307-7. Epub 2019 Dec 9.
10
Performance of common imaging techniques serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis.常见成像技术和血清生物标志物在评估慢性乙型肝炎患者肝纤维化中的性能:一项系统评价和荟萃分析。
World J Clin Cases. 2019 Aug 6;7(15):2022-2037. doi: 10.12998/wjcc.v7.i15.2022.